ESR1 and breast carcinoma: We propose that the competition for the steroid receptor coactivator AIB1, that is important in the functional coupling of the ERα with the cyclin D1 promoter [28], may represent a possible mechanism through which AR can modulate ERα-mediated signalling pathway on cyclin D1 gene leading to the inhibition of breast cancer cell proliferation.